[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"lung-surgery\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:lung-surgery":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,40,65,87,119,149,178,198],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":28,"lastUpdatePostDateStruct":29,"startDateStruct":32,"completionDateStruct":34,"leadSponsor":36,"locationsCount":39},"100620801","right-ventricle-response-to-major-lung-resection-in-vats-and-robotic-surgery-100620801",false,"NCT07362342","RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery","RIght VEntricle Response to Major Lung Resection in VATS and Robotic Surgery (the RIVER-2 Study)","RIVER-2","Inclusion Criteria:\n\n* Adult patients aged ≥18 years\n* Scheduled for elective lobectomy (or bilobectomy) via minimally invasive or open thoracic surgery\n* Ability to provide written informed consent at the time of hospital admission\n* Moderate to high cardiopulmonary risk, defined by at least one of the following criteria:\n\n  * ASA physical status classification 3\n  * Predicted postoperative FEV1 \\\u003C60% and 6-minute walk test \\\u003C400 m or cardiopulmonary exercise test \\\u003C20 ml\u002Fkg\u002Fmin\n  * DASI index \\\u003C34\n  * RCRI \\>2\n  * Coronary artery disease\n  * Heart failure\n  * Right ventricular systolic dysfunction (TAPSE \\\u003C17 mm and\u002For S' wave on TDI \\\u003C10 cm\u002Fs)\n  * Left ventricular systolic dysfunction (EF \\\u003C55%)\n\nExclusion Criteria\n\n* Urgent\u002Femergency surgery\n* History of pulmonary embolism\n* Previous right or left pneumonectomy\n* Previous lobectomy\n* Completion pneumonectomy\n* Pregnancy (confirmed or suspected)\n* History of severe pulmonary hypertension (PAPs \\>40 mmHg)","ALL","18 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","Major pulmonary resection is associated with high postoperative morbidity and mortality, mainly due to cardiorespiratory complications. Right ventricular (RV) function is closely related to pulmonary artery pressure and tone, and it is particularly sensitive to changes in afterload. An increase in RV flow resistance can lead to acute RV dilation and reduced left ventricular compliance, potentially progressing to cardiogenic shock. In a previous study (RIVER), it was observed that increased afterload following open thoracic surgery reduces RV function, although this impairment remains subclinical. The aim of this study is to investigate the same parameters in patients with severe cardiovascular comorbidities undergoing pulmonary resection via minimally invasive approaches (VATS and robotic surgery) compared to open thoracotomy.",[25,26],"Lung Surgery","Right Ventricular Function","RECRUITING","2026-06-22",{"date":30,"type":31},"2026-06-25","ACTUAL",{"date":33,"type":31},"2026-01-20",{"date":35,"type":21},"2027-12-01",{"name":37,"class":38},"Istituto Clinico Humanitas","OTHER",1,{"id":41,"slug":42,"hasResults":11,"nctId":43,"briefTitle":44,"officialTitle":44,"acronym":45,"eligibilityCriteria":46,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":47,"targetDuration":4,"studyType":49,"phases":50,"briefSummary":52,"conditions":53,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":55,"lastUpdatePostDateStruct":56,"startDateStruct":58,"completionDateStruct":60,"leadSponsor":62,"locationsCount":64},"100611970","impact-of-reventilation-after-one-lung-ventilation-in-thoracic-surgery-olvreexp-100611970","NCT07247500","Impact of Reventilation After One-Lung Ventilation in Thoracic Surgery (OLVREEXP)","OLVREEXP","Inclusion Criteria:\n\n* ASA score ≤ 3.\n* Undergoing a scheduled video-assisted or robot-assisted lobectomy or segmentectomy.\n* Patient has read and understood the information sheet and signed the informed consent form.\n* For women of childbearing potential, effective contraception and confirmation of the absence of an ongoing pregnancy by a negative blood or urine pregnancy test are required.\n* Postmenopausal women (spontaneous, non-medically induced amenorrhea for at least 12 months prior to the inclusion visit).\n* Patient affiliated with a social security system.\n\nExclusion Criteria:\n\n* Patients with a BMI \\> 40 kg\u002Fm².\n* Patients with severe chronic respiratory failure (COPD grade 3, FEV₁\u002FFVC \\\u003C 0.7 and FEV₁ \\\u003C 50% - according to the GOLD 2025 classification).\n* Patients with severe chronic renal failure (GFR \\\u003C 30 mL\u002Fmin).\n* Patients at high risk of conversion to thoracotomy.\n* Patients with a history of acute respiratory distress syndrome (ARDS) within 3 months prior to surgery.\n* Patients with a known history of severe hepatic failure (Child-Pugh class B or C).\n* Patients with a history of heart failure (NYHA class ≥ II).\n* Patients with a history of pulmonary resection.\n* Patients with uncontrolled asthma.\n* Pregnant or breastfeeding women.\n* Patients deprived of liberty by administrative or judicial decision, as well as those under legal protection, guardianship, or curatorship.",{"count":48,"type":21},350,"INTERVENTIONAL",[51],"NA","Lung cancer is a common disease, and more than 8,000 patients in France undergo lobectomy or pulmonary segmentectomy each year. This surgery remains associated with significant postoperative pulmonary complications, whose incidence ranges from 15% to 49% depending on the study (1). The main complication is pulmonary atelectasis, which provides a favorable setting for the development of postoperative pneumonia.\n\nIn thoracic surgery, the operated lung is excluded, and one-lung ventilation is performed on the contralateral lung. During surgery, several strategies exist to prevent atelectasis during one-lung ventilation, known as protective ventilation strategies (2). At the end of the procedure, reventilation allows re-expansion of the previously excluded lung.\n\nHowever, pulmonary reventilation induces the release of pro-inflammatory cytokines and causes endothelial dysfunction, which may lead to pulmonary edema, thereby negating the benefits of intraoperative protective ventilation. Conversely, insufficient re-expansion may result in persistent postoperative atelectasis, whereas excessive re-expansion can cause volutrauma, alveolar trauma, and\u002For barotrauma to the operated lung (3).\n\nSeveral reventilation techniques are currently used, but to our knowledge, the impact of reventilation itself has never been specifically studied. The first, empirical technique, consists of reventilating both lungs using the accessory circuit and the adjustable pressure-limiting (APL) valve, manually bagging the patient over several respiratory cycles (4). The main drawback of this method is the lack of monitoring of insufflated volumes and pressures.\n\nThe second, more recent technique, consists of reventilating the patient using the anesthesia machine circuit in controlled ventilation mode, which allows for precise monitoring of pressures and insufflated volumes (5). This approach provides real-time monitoring of lung re-expansion and could therefore be less harmful than the empirical method.\n\nThus, the objective of this study is to compare postoperative pulmonary complications between patients who underwent lung re-expansion using the accessory circuit and those who underwent lung re-expansion using the anesthesia machine circuit in controlled ventilation mode.",[25],"NOT_YET_RECRUITING","2026-06-05",{"date":57,"type":31},"2026-06-09",{"date":59,"type":21},"2026-07-01",{"date":61,"type":21},"2028-08-01",{"name":63,"class":38},"University Hospital, Rouen",5,{"id":66,"slug":67,"hasResults":11,"nctId":68,"briefTitle":69,"officialTitle":69,"acronym":70,"eligibilityCriteria":71,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":72,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":78,"lastUpdatePostDateStruct":79,"startDateStruct":81,"completionDateStruct":83,"leadSponsor":85,"locationsCount":39},"100619872","prospective-study-evaluating-the-effectiveness-of-intraoperative-ventilation-for-predicting-postoperative-air-leaks-during-major-lung-resections-by-conventional-or-robotic-thoracoscopy-100619872","NCT07350265","Prospective Study Evaluating the Effectiveness of Intraoperative Ventilation for Predicting Postoperative Air Leaks During Major Lung Resections by Conventional or Robotic Thoracoscopy","NODRAIN","Inclusion Criteria:\n\n* Patient with pulmonary lobectomy or Anatomical segmentectomy with closed chest (conventional or robotic thoracoscopy);\n* Patient affiliated with a health insurance scheme.\n* Person who has not objected to the collection of his\u002Fher data for the purpose of the study.\n\nExclusion Criteria:\n\n* Patient undergoing any type of lung resection by thoracotomy;\n* Patient with a history of thoracic surgery on the same side;\n* Patient with pulmonary fibrosis;\n* Patient from a vulnerable population as defined in Articles L.1121-5 to 8 of the French Public Health Code.\n* Patient undergoing conversion to thoracotomy;\n* Patient undergoing conversion from planned pulmonary lobectomy or anatomical segmentectomy to atypical resection, bilobectomy or pneumonectomy;\n* Drainage via two chest drains;\n* Absence of autonomous drainage system;\n* Patient not extubated at the end of the procedure;\n* Early reoperation, before drain removal, due to complications.",{"count":20,"type":21},"Air leak from lung after major pulmonary resections is alveolar-pleural microfistulas resulting from damage to the visceral pleura during lung surgery. Despite advances in stapling techniques and repair methods to ensure pulmonary tightness after excision, air leak is the most common cause of prolonged hospital stay after lung surgery, accounting for 20 to 30% of post-surgical adverse events.\n\nAlthough painless, they remain a significant source of morbidity. 10 to 20% of patients may have a prolonged air leak requiring intervention. Prolonged air leak is defined as an air leakage that persists for 5 days or more. Prolonged air leak is independently associated with increased hospitalization costs of 18% to 27% according to the series reported in the literature, but also with increased costs after hospital discharge, up to 90 days postoperatively.\n\nTraditionally, the detection of air leak at the end of surgery is done by testing the lung for submersion in saline solution. With the development of major pulmonary resection techniques by conventional or robotic thoracoscopy (with closed chest), this method has become ineffective because it requires re-ventilating the lung in a closed rib cage, which cancels the visibility of the camera. However, the frequency of these adverse events and the morbidity associated with them now induces the placement of post-operative drains, which are very painful, unlike the leak itself, which makes the pain even more complex to bear for patients.\n\nGiven the rapid transition to a minimally invasive surgical approach, having a method to detect and quantify intraoperative air leak on a closed chest is necessary in order to accelerate patients' postoperative recovery, reducing their postoperative pain while controlling the incidence of complications.\n\nA recent study has shown that the risk of postoperative air leak is possible based exclusively on intraoperative ventilator measurements, but the data are still too scarce to rely on them extensively.",[75,25],"Air Leak From Lung",[77],"intraoperative ventilation","2026-03-27",{"date":80,"type":31},"2026-03-30",{"date":82,"type":31},"2026-01-14",{"date":84,"type":21},"2026-12",{"name":86,"class":38},"GCS Ramsay Santé pour l'Enseignement et la Recherche",{"id":88,"slug":89,"hasResults":11,"nctId":90,"briefTitle":91,"officialTitle":92,"acronym":4,"eligibilityCriteria":93,"healthyVolunteers":11,"sex":17,"minAge":94,"maxAge":4,"enrollmentInfo":95,"targetDuration":4,"studyType":49,"phases":97,"briefSummary":98,"conditions":99,"keywords":107,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":110,"lastUpdatePostDateStruct":111,"startDateStruct":113,"completionDateStruct":115,"leadSponsor":117,"locationsCount":39},"100555754","auricular-acupressure-in-prehabilitation-100555754","NCT06516198","Auricular Acupressure in Prehabilitation","A Pilot Study of the Utility of Auricular Acupressure in Enhancing Prehabilitation Benefits in Candidates for Thoracic Surgery.","Inclusion Criteria\n\n* Being considered for major lung surgery\n* Surgery is not scheduled for at least 2 weeks\n* Age ≥ 50 years\n* Able to understand English at a 4th grade level\n* No known contraindications to prehabilitation (strength, endurance, balance exercises)\n* Able to provide informed consent for participation\n* Has an adult care partner who will be available and capable of placing seeds\n* Has access to smart phone for communication and image sharing\n* Underwent frailty screening (given any score)\n* Able to perform spirometry testing in clinic\n\nExclusion Criteria:\n\n* Allergy to Vaccaria seeds\n* Medical condition affecting either ear preventing use of auricular acupressure such as eczema, frostbite, sunburn","50 Years",{"count":96,"type":21},40,[51],"Complementary medicine is recognized for its ability to enhance appetite, increase energy, reduce anxiety, decrease pain, and improve sleep, among many other benefits. Acupuncture is among the most frequent types of complementary medicine practiced in the US, and Medicare currently includes back pain as a reimbursable indication for this therapy. Acupuncture-related therapies may enhance efforts at prehabilitation in candidates for major lung resection.",[100,101,102,25,103,104,105,106],"Frailty","Thoracic","Prehabilitation","Wedge Resection","Segmentectomy","Lobectomy","Pneumonectomy; Status",[108,109],"accupressure","vaccaria seeds","2025-12-02",{"date":112,"type":31},"2025-12-09",{"date":114,"type":31},"2025-07-21",{"date":116,"type":21},"2027-06-20",{"name":118,"class":38},"University of Chicago",{"id":120,"slug":121,"hasResults":11,"nctId":122,"briefTitle":123,"officialTitle":124,"acronym":4,"eligibilityCriteria":125,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":126,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":128,"conditions":129,"keywords":133,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":142,"completionDateStruct":144,"leadSponsor":146,"locationsCount":148},"100587268","safety-efficacy-and-survival-outcomes-of-neoadjuvantinduction-immunotherapy-in-surgical-and-radiotherapeutic-management-of-non-small-cell-lung-cancer-100587268","NCT06926179","Safety, Efficacy, and Survival Outcomes of Neoadjuvant\u002FInduction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer","Safety, Efficacy, and Survival Outcomes of Neoadjuvant\u002FInduction Immunotherapy in Surgical and Radiotherapeutic Management of Non-Small Cell Lung Cancer: A Multicenter Real-World Study","Inclusion Criteria:\n\n1. Histologically confirmed non-small cell lung cancer (NSCLC), regardless of the presence of EGFR or ALK sensitive driver gene mutations;\n2. Clinical staging of IA-IIIC according to the AJCC 8th Edition before neoadjuvant treatment;\n3. Received at least one cycle of neoadjuvant immunotherapy (with or without chemotherapy);\n4. Assessed as resectable or potentially resectable by surgical experts prior to treatment.\n\nExclusion Criteria:\n\n1. Confirmed M1 disease;\n2. History of previous lung malignancy or other metastatic malignant tumors;\n3. Participation in other randomized controlled trials involving neoadjuvant treatment;\n4. Significant missing clinical data.",{"count":127,"type":21},500,"This multicenter retrospective real-world study aims to evaluate the safety, efficacy and survival outcomes of neoadjuvant\u002Finduction immunotherapy in patients with non-small cell lung cancer (NSCLC). The study covers diverse treatment pathways, including surgery, definitive radiotherapy, and non-surgical strategies. It addresses gaps in existing trials by establishing a comprehensive cohort spanning neoadjuvant\u002Finduction therapy, perioperative management, and follow-up, providing real-world evidence to support treatment decisions in both operable and inoperable cases.",[130,131,132,25],"Lung Cancer (NSCLC)","Neoadjuvant Immunotherapy","Radiotherapy",[134,135,136,137,138],"lung cancer","neoadjuvant immunotherapy","real-world study","radiotherapy","thoracic surgery","2025-04-11",{"date":141,"type":31},"2025-04-16",{"date":143,"type":31},"2024-12-01",{"date":145,"type":21},"2028-03-31",{"name":147,"class":38},"Peking University Cancer Hospital & Institute",4,{"id":150,"slug":151,"hasResults":11,"nctId":152,"briefTitle":153,"officialTitle":153,"acronym":154,"eligibilityCriteria":155,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":156,"targetDuration":4,"studyType":49,"phases":158,"briefSummary":159,"conditions":160,"keywords":161,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":168,"lastUpdatePostDateStruct":169,"startDateStruct":171,"completionDateStruct":173,"leadSponsor":175,"locationsCount":177},"100562010","evaluation-of-the-effectiveness-and-security-of-tenatac-in-the-prevention-of-air-leaks-in-thoracic-surgery-100562010","NCT06597604","Evaluation of the Effectiveness and Security of TenaTac® in the Prevention of Air Leaks in Thoracic Surgery","TENATAC","Inclusion Criteria:\n\n* Patients hospitalized in the thoracic surgery departments of the investigating centers, for elective surgery,\n* Lobectomy surgery requiring the use of a sealing agent,\n* Adult patients (\\>18 years),\n* Patients who have given written consent to participate in the study,\n* Patients registered within the social security insurance in France.\n\nExclusion Criteria:\n\n* Patients hospitalized in emergency,\n* Patients with gelatin allergy,\n* Patients undergoing other biomedical research likely to interfere with the evaluation criteria of this study\n* Patients under tutorship and\u002For curatorship,\n* Patients unable to follow the planned post-operative follow-up,\n* Patients whose life expectancy is less than 1 year,\n* Pregnant or breast-feeding patients.",{"count":157,"type":21},154,[51],"Lung surgery remains a high-risk procedure, with serious adverse events that can occur later, including postoperative bleeding or hemothorax, pneumopathy or surgical site infection but also ... per- and post-operative air leaks. Majority the air leaks resolve spontaneously within 48 hours but certain cases persist within several days which known as prolonged air leaks, or PAL. Several safe and effective sealing agents are used to contain and or reduce the intensity and incidence of postoperative air leaks, and the time required for drain removal. This protocol assesses the effectiveness of an innovative gelatin-based medical device named TenaTac® (Selentus Science, UK) in preventing air leak after major lung resection.",[25],[162,163,164,165,166,167,105],"Lung surgery","TenaTac","Gelatin Patch","Sealant","PAL","Pulmonary Air Leak","2025-01-30",{"date":170,"type":31},"2025-02-03",{"date":172,"type":21},"2025-03-01",{"date":174,"type":21},"2026-06-30",{"name":176,"class":38},"Hopitaux Prives de Metz, Groupe UNEOS",2,{"id":179,"slug":180,"hasResults":11,"nctId":181,"briefTitle":182,"officialTitle":183,"acronym":4,"eligibilityCriteria":184,"healthyVolunteers":11,"sex":17,"minAge":4,"maxAge":4,"enrollmentInfo":185,"targetDuration":4,"studyType":49,"phases":187,"briefSummary":188,"conditions":189,"keywords":4,"overallStatus":54,"whyStopped":4,"lastUpdateSubmitDate":190,"lastUpdatePostDateStruct":191,"startDateStruct":192,"completionDateStruct":194,"leadSponsor":196,"locationsCount":39},"100578012","ventilation-strategies-impact-on-oxygenation-and-postoperative-pulmonary-complications-in-lung-surgery-patients-100578012","NCT06805760","Ventilation Strategies Impact on Oxygenation and Postoperative Pulmonary Complications in Lung Surgery Patients","Ventilation Strategies Impact on Oxygenation and Postoperative Pulmonary Complications in Lung Surgery Patients: a Prospective, Randomized, Triple-Blind Trial","Inclusion Criteria:\n\n* Patients requiring any of open surgery, television-assisted thoracoscopic surgery (VATS), segmental lung resection (Segmentectomy), lobectomy, and total lung resection (Pneumonectomy).\n* Patients who are able to receive any of the ventilation modes of controlled ventilation (C - VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C - VCV), pressure-controlled ventilation (PCV), and variable tidal volume ventilation (V - VCV).\n\nExclusion Criteria:\n\n* Patients with severe cardiac, hepatic, renal, and other vital organ dysfunction\n* Patients with mental illness or cognitive disorders that prevent them from understanding the study and cooperating with the study process.\n* Patients with hematologic disorders\n* Pregnant or breastfeeding females",{"count":186,"type":21},120,[51],"The purpose of this clinical trial was to understand the effects of variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), pressure-controlled ventilation (PCV), and open surgery (Open Surgery). controlled ventilation (C-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), and pressure-controlled ventilation (PCV) for open surgery, video-assisted thoracoscopic surgery, and segmental lung resection. VATS), segmentectomy (Segmentectomy), lobectomy (Lobectomy), and pneumonectomy (Pneumonectomy) on oxygen saturation and pulmonary complications, and length of hospitalization.\n\nThe main question it aims to answer is: variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), and pressure-controlled ventilation (PCV).Does it decrease patient oxygen saturation, and does it increase pulmonary complications, length of hospitalization? Researchers compared variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume-controlled ventilation (C-VCV), and pressure-controlled ventilation (PCV) to compare them to see which mode of ventilation has the least physiologic disruption for the patient.\n\nParticipants will:\n\nSelect the appropriate surgical procedure according to the condition and be randomized to variable tidal volume ventilation (V-VCV), pressure-regulated volume-controlled ventilation (PRVC), conventional volume- controlled ventilation (C-VCV), pressure-controlled ventilation (PCV), and were checked after surgery.\n\nPatients' oxygen saturation, pulmonary complications, length of hospitalization were recorded",[25],"2025-01-28",{"date":170,"type":31},{"date":193,"type":21},"2025-02-01",{"date":195,"type":21},"2025-05-10",{"name":197,"class":38},"Inner Mongolia Baogang Hospital",{"id":199,"slug":200,"hasResults":11,"nctId":201,"briefTitle":202,"officialTitle":202,"acronym":203,"eligibilityCriteria":204,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":205,"targetDuration":4,"studyType":49,"phases":207,"briefSummary":208,"conditions":209,"keywords":4,"overallStatus":27,"whyStopped":4,"lastUpdateSubmitDate":212,"lastUpdatePostDateStruct":213,"startDateStruct":215,"completionDateStruct":217,"leadSponsor":219,"locationsCount":39},"100550267","patient-reported-outcomes-targeting-early-chest-tube-removal-protectr-study-100550267","NCT06444854","Patient Reported Outcomes Targeting Early Chest Tube Removal (PROTECTR) Study","PROTECTR","Inclusion Criteria:\n\n* 18 yrs or older\n* scheduled to undergo elective VATS segmental or lobar resection of the lung\n\nExclusion Criteria:\n\n* Pulmonary function tests demonstrating forced expiratory volume in 1 second Forced Expiratory Volume (FEV1) \\\u003C50% predicted, FEV1 \\\u003C1.5L and\u002For diffusion lung capacity of carbon monoxide Lung Diffusion Test (DLCO) \\\u003C50% predicted\n* Patient receives an intraoperative pleurodesis\n* Conversion to open thoracotomy or mini thoracotomy intraoperatively.\n* Underlying cognitive disorder resulting in inability to complete activities of daily living.",{"count":206,"type":21},130,[51],"This study is a single centre, prospective clinical trial evaluating the safety and feasibility of implementing a same day chest tube removal protocol in patients undergoing Video Assisted Thoracic Surgery (VATS) anatomical pulmonary surgery.",[25,210,211],"Chest Tube Removal","Enhanced Recovery After Surgery (ERAS)","2024-10-24",{"date":214,"type":31},"2024-10-28",{"date":216,"type":31},"2024-10-22",{"date":218,"type":21},"2026-12-31",{"name":220,"class":38},"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's"]